The Future of Home Diagnostics and OTC Health Products

By: Sushil Suri, Chairman & MD at Morepen Laboratories

The home diagnostics landscape in India is evolving, with a potential growth from $11 billion to $50 billion by 2030. Expansion into digital weighing scales, thermometers, and oximeters, along with R&D efforts, marks a promising future.

Emerging Technology Leaders: Current CDMO Trend in Pharma Industry

By: Udaya Kumar Nayak, Head & GM – Formulation & Development, Marksans Pharma

The emerging trends of CDMOs reflect the country's growing prominence as a preferred outsourcing destination for drug development and manufacturing activities The growth and evolution of the CDMO industry have been driven by factors such as cost a...

Personalized Medicine in Psoriasis: Tailoring Treatment to Individuals

By: Tarun Kumar, CEO, Lord’s Mark Biotech

Psoriasis commonly affects individuals in their 30’s or 40’s, with males being affected two times more commonly than females. Psoriasis prevalence is 1.6% among people aged 20 to 29 years and 4.3% among those aged 50 to 59 years

Telemedicine Spectacle: Reimagine India's Health in the Next Couple of Years

By: Ayush Atul Mishra, CEO and Co-Founder, Tattvan E-Clinics.

India is home to 1.4 billion people, of who close to two-thirds reside in rural areas.

Predictive Maintenance: The Backbone of Medical Devices Industry

By: Venkatnarayanan K, Sr. Vice President and Head-Customer Services Zone India, Siemens Healthineers

Excerpts from a conversation with Venkatnarayanan K, Sr. Vice President & Head-Customer Services Zone India, Siemens Healthineers in which he speaks about the evolution of predictive maintenance, & how it is helping with resource & cost optimization.

Revitalizing the Medical Device Industry by Focusing on Quality and Innovation

By: Rishubh Gupta, GM, Baxter India

The medical devices market in India has the potential to increase at a 37% CAGR and reach $ 50 bn by 2025. Several factors including favorable policies such as 100% FDI in the sector, a reduction in regulatory burden and ongoing improvements contri..

© 2024 India Pharma Outlook. All Rights Reserved.